Micro Tech Nanjing Co Ltd

SHG:688029 China Medical Instruments & Supplies
Market Cap
$1.90 Billion
CN¥13.91 Billion CNY
Market Cap Rank
#7244 Global
#1219 in China
Share Price
CN¥74.04
Change (1 day)
-1.37%
52-Week Range
CN¥56.98 - CN¥100.35
All Time High
CN¥225.35
About

Micro-Tech (Nanjing) Co.,Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of invasive medical devices in China and internationally. The company offers digestive endoscopy products, including ESD, such as electric flushing device, harmony/GT gold clip, gold/titanium knife, pull clamp, three-arm clap, hemostatic titanium forceps, injection needle, v… Read more

Micro Tech Nanjing Co Ltd (688029) - Net Assets

Latest net assets as of September 2025: CN¥4.24 Billion CNY

Based on the latest financial reports, Micro Tech Nanjing Co Ltd (688029) has net assets worth CN¥4.24 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.19 Billion) and total liabilities (CN¥948.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.24 Billion
% of Total Assets 81.73%
Annual Growth Rate 34.27%
5-Year Change 46.39%
10-Year Change 1198.98%
Growth Volatility 69.3

Micro Tech Nanjing Co Ltd - Net Assets Trend (2006–2024)

This chart illustrates how Micro Tech Nanjing Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Micro Tech Nanjing Co Ltd (2006–2024)

The table below shows the annual net assets of Micro Tech Nanjing Co Ltd from 2006 to 2024.

Year Net Assets Change
2024-12-31 CN¥3.90 Billion +6.25%
2023-12-31 CN¥3.67 Billion +12.08%
2022-12-31 CN¥3.27 Billion +9.50%
2021-12-31 CN¥2.99 Billion +12.26%
2020-12-31 CN¥2.66 Billion +5.36%
2019-12-31 CN¥2.53 Billion +307.51%
2018-12-31 CN¥620.37 Million +33.07%
2017-12-31 CN¥466.19 Million +29.88%
2016-12-31 CN¥358.94 Million +19.57%
2015-12-31 CN¥300.19 Million +14.42%
2014-12-31 CN¥262.35 Million +12.56%
2013-12-31 CN¥233.07 Million +98.96%
2011-12-31 CN¥117.14 Million +36.76%
2010-12-31 CN¥85.66 Million +34.67%
2009-12-31 CN¥63.61 Million +44.39%
2008-12-31 CN¥44.05 Million +44.43%
2007-12-31 CN¥30.50 Million +57.38%
2006-12-31 CN¥19.38 Million --

Equity Component Analysis

This analysis shows how different components contribute to Micro Tech Nanjing Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 16677.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.66 Billion 43.50%
Common Stock CN¥187.85 Million 4.91%
Other Comprehensive Income CN¥302.92 Million 7.92%
Other Components CN¥1.67 Billion 43.68%
Total Equity CN¥3.83 Billion 100.00%

Micro Tech Nanjing Co Ltd Competitors by Market Cap

The table below lists competitors of Micro Tech Nanjing Co Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Micro Tech Nanjing Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 3,611,919,944 to 3,826,092,661, a change of 214,172,717 (5.9%).
  • Net income of 553,226,641 contributed positively to equity growth.
  • Dividend payments of 280,814,088 reduced retained earnings.
  • Share repurchases of 60,013,409 reduced equity.
  • Other comprehensive income increased equity by 296,675,614.
  • Other factors decreased equity by 294,902,041.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥553.23 Million +14.46%
Dividends Paid CN¥280.81 Million -7.34%
Share Repurchases CN¥60.01 Million -1.57%
Other Comprehensive Income CN¥296.68 Million +7.75%
Other Changes CN¥-294.90 Million -7.71%
Total Change CN¥- 5.93%

Book Value vs Market Value Analysis

This analysis compares Micro Tech Nanjing Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.63x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 512.37x to 3.63x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 CN¥0.14 CN¥74.04 x
2007-12-31 CN¥0.23 CN¥74.04 x
2008-12-31 CN¥0.33 CN¥74.04 x
2009-12-31 CN¥0.48 CN¥74.04 x
2010-12-31 CN¥0.64 CN¥74.04 x
2011-12-31 CN¥0.88 CN¥74.04 x
2013-12-31 CN¥12.02 CN¥74.04 x
2014-12-31 CN¥3.75 CN¥74.04 x
2015-12-31 CN¥2.25 CN¥74.04 x
2016-12-31 CN¥2.52 CN¥74.04 x
2017-12-31 CN¥3.11 CN¥74.04 x
2018-12-31 CN¥4.14 CN¥74.04 x
2019-12-31 CN¥15.52 CN¥74.04 x
2020-12-31 CN¥13.99 CN¥74.04 x
2021-12-31 CN¥15.56 CN¥74.04 x
2022-12-31 CN¥17.07 CN¥74.04 x
2023-12-31 CN¥19.25 CN¥74.04 x
2024-12-31 CN¥20.40 CN¥74.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Micro Tech Nanjing Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 14.46%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 20.08%
  • • Asset Turnover: 0.58x
  • • Equity Multiplier: 1.25x
  • Recent ROE (14.46%) is below the historical average (20.94%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 37.68% 29.38% 0.81x 1.59x CN¥5.35 Million
2007 46.37% 33.23% 0.82x 1.70x CN¥11.07 Million
2008 40.38% 28.82% 0.92x 1.53x CN¥13.38 Million
2009 38.07% 29.65% 0.93x 1.39x CN¥17.85 Million
2010 37.41% 29.77% 0.76x 1.65x CN¥23.48 Million
2011 27.11% 24.93% 0.71x 1.52x CN¥20.04 Million
2013 10.69% 14.72% 0.59x 1.24x CN¥1.60 Million
2014 11.17% 14.45% 0.62x 1.25x CN¥3.06 Million
2015 11.04% 12.01% 0.56x 1.64x CN¥2.95 Million
2016 -10.90% -8.80% 0.77x 1.62x CN¥-69.91 Million
2017 23.22% 15.79% 0.89x 1.65x CN¥57.61 Million
2018 33.24% 20.90% 0.95x 1.67x CN¥134.73 Million
2019 12.27% 23.22% 0.45x 1.16x CN¥56.09 Million
2020 9.99% 19.66% 0.43x 1.19x CN¥-334.57K
2021 11.03% 16.68% 0.54x 1.23x CN¥30.42 Million
2022 10.25% 16.70% 0.51x 1.21x CN¥8.09 Million
2023 13.45% 20.15% 0.55x 1.22x CN¥124.73 Million
2024 14.46% 20.08% 0.58x 1.25x CN¥170.62 Million

Industry Comparison

This section compares Micro Tech Nanjing Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,246,530,775
  • Average return on equity (ROE) among peers: 12.28%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Micro Tech Nanjing Co Ltd (688029) CN¥4.24 Billion 37.68% 0.22x $1.02 Billion
Beijing Centergate Technologies Holding Co Ltd (000931) $2.03 Billion -9.26% 2.64x $356.80 Million
Blue Sail Medical Co Ltd (002382) $10.54 Billion 10.97% 0.61x $760.18 Million
Andon Health Co Ltd (002432) $758.75 Million 1.34% 0.32x $2.33 Billion
Allmed Medical Products Co Ltd Class A (002950) $2.75 Billion 15.67% 0.82x $360.97 Million
Guangzhou Improve Med Instrument (300030) $592.55 Million 4.90% 0.10x $242.74 Million
Shanghai Tofflon Science Tech (300171) $2.41 Billion 11.06% 0.57x $802.27 Million
Truking Technology Ltd (300358) $320.32 Million 29.77% 1.35x $556.14 Million
Jiangxi Sanxin Medtec Co Ltd (300453) $1.41 Billion 16.14% 0.58x $438.45 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573) $1.55 Billion 13.64% 0.15x $1.61 Billion
Autek China Inc (300595) $105.24 Million 28.59% 0.10x $1.21 Billion